#Cannabis
Experts Join True Leaf (CSE: $MJ) (FSE: $TLA) Team for Final Marijuana
Licensing Review Stage
Experts will advise on production
facility design and build, security, and product testing before pre-license
inspection
Vancouver, British Columbia - April
24, 2017 (Newsfile Corp.) (Investorideas.com Newswire) True Leaf Medicine Inc.
(True Leaf), a division of True Leaf Medicine International Ltd. (CSE: MJ)
(FSE: TLA), has engaged a number of cannabis experts to guide the company
through the final stage in Health Canada's review of its application for a
license to produce marijuana in Canada.
Experts from industry-leading Pipe
Dreemz Inc., Protect-IP Global Solutions Inc., Eurofins Scientific, and Ample
Organics will be working with True Leaf over the next few weeks to prepare a
review package for submission to Health Canada under the Access to Cannabis for
Medical Purposes Regulations (ACMPR) application process.
Health Canada recently upgraded the
Marihuana for Medical Purposes Regulations (MMPR) application process to the
ACMPR licensing program, so the experts will be working with True Leaf to
update its original MMPR application to ensure True Leaf meets or exceeds the
new compliance measures.
"True Leaf is excited to have
Pipe Dreemz, Protect-IP, Eurofins, and Ample Organics provide their expertise
at this critical stage in the ACMPR review process," said True Leaf CEO
Darcy Bomford. "We sought out experts from these companies because several
of their clients have already been successful in the ACMPR process."
True Leaf has engaged Pipe Dreemz CEO
George Routhier, a premier consultant to companies going through Health
Canada's Marihuana for Medical Purposes Regulations (MMPR) or ACMPR process
since 2012. Mr. Routhier helps his clients navigate the complexities of the
licensing process, specifically the design, construction, and operating
procedures of marijuana production facilities. Pipe Dreemz is currently
advising clients with over $150 million in production facilities under
construction in Canada.
Protect-IP will advise True Leaf on
the Physical Safety Integration of its planned production facility.
Protect-IP's engineering team has worked with companies in all phases of the
licensing process, and will work with True Leaf on developing procedures for
control systems, alarm systems, and CCTV using IP technology to ensure True
Leaf builds and operates a safe and secure production facility.
Eurofins, a leading international
group of laboratories with more than 22,000 employees across 225 sites in 39
countries, will help True Leaf test its marijuana products to ensure it
complies with Health Canada regulations. Eurofins works with the
pharmaceutical, food, environmental, and consumer products industries on a
wide-range of scientific testing and support services.
True Leaf has also engaged Ample
Organics, the most widely adopted seed-to-sale reporting system among Canada's
licensed marijuana producers.
"We are pleased to be working
with True Leaf, a late stage ACMPR applicant," said Pipe Dreemz CEO George
Routhier. "Darcy and his team have chosen to accelerate their final push
to the finish line, and together we expect to receive their pre-license
inspection in the very near future."
About True Leaf:
True Leaf Medicine International
Ltd., through its wholly-owned subsidiary 'True Leaf Pet', has entered the
$104.9 billion global pet care industry with a line of hemp-focused pet chews
and supplements marketed through natural pet health and veterinary channels in
Canada, the United States and Europe. The company has also filed an application
under Health Canada's Access to Cannabis for Medical Purposes Regulations
(ACMPR) to become a Canadian licensed producer through its 'True Leaf Medicine'
subsidiary. It has passed through the security screening process of Health
Canada's review and is currently in the final review stage before the
'pre-licensing inspection' approval.
Media Contact:
Paul Sullivan
BreakThrough Communications
p.sullivan@breakthroughpr.com
O: 604-685-4742
M: 604-603-7358
BreakThrough Communications
p.sullivan@breakthroughpr.com
O: 604-685-4742
M: 604-603-7358
Investor Contact:
Kevin Bottomley
Director and Corporate Relations
kevin@trueleaf.com
M: 778-389-9933
Director and Corporate Relations
kevin@trueleaf.com
M: 778-389-9933
Marijuana
/ Hemp Stocks
Watch the 420
Cannabis Investor video
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment